Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)

E. Drakos, R. R. Singh, G. Z. Rassidakis, E. Schlette, J. Li, F. X. Claret, R. J. Ford, F. Vega, L. J. Medeiros

Research output: Contribution to journal › Article › peer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)'. Together they form a unique fingerprint.

Medicine & Life Sciences